Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 574 | 3206 | 31.1 | 67% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 701 | 12232 | RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS | Journal | 62 | 52% | 3% | 85 |
| 2 | RADIOIMMUNOGUIDED SURGERY | Author keyword | 50 | 84% | 1% | 27 |
| 3 | IMMUNOSCINTIGRAPHY | Author keyword | 36 | 40% | 2% | 71 |
| 4 | RADIOIMMUNODETECTION | Author keyword | 27 | 41% | 2% | 51 |
| 5 | MONOCLONAL ANTIBODY A7 | Author keyword | 21 | 85% | 0% | 11 |
| 6 | RADIOIMMUNOSCINTIGRAPHY | Author keyword | 19 | 40% | 1% | 38 |
| 7 | RADIOIMMUNOTHERAPY | Author keyword | 18 | 12% | 5% | 145 |
| 8 | TAG 72 | Author keyword | 15 | 47% | 1% | 23 |
| 9 | RADIOIMMUNOTARGETING | Author keyword | 11 | 67% | 0% | 10 |
| 10 | RADIOIMMUNOLOCALIZATION | Author keyword | 11 | 78% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | RADIOIMMUNOGUIDED SURGERY | 50 | 84% | 1% | 27 | Search RADIOIMMUNOGUIDED+SURGERY | Search RADIOIMMUNOGUIDED+SURGERY |
| 2 | IMMUNOSCINTIGRAPHY | 36 | 40% | 2% | 71 | Search IMMUNOSCINTIGRAPHY | Search IMMUNOSCINTIGRAPHY |
| 3 | RADIOIMMUNODETECTION | 27 | 41% | 2% | 51 | Search RADIOIMMUNODETECTION | Search RADIOIMMUNODETECTION |
| 4 | MONOCLONAL ANTIBODY A7 | 21 | 85% | 0% | 11 | Search MONOCLONAL+ANTIBODY+A7 | Search MONOCLONAL+ANTIBODY+A7 |
| 5 | RADIOIMMUNOSCINTIGRAPHY | 19 | 40% | 1% | 38 | Search RADIOIMMUNOSCINTIGRAPHY | Search RADIOIMMUNOSCINTIGRAPHY |
| 6 | RADIOIMMUNOTHERAPY | 18 | 12% | 5% | 145 | Search RADIOIMMUNOTHERAPY | Search RADIOIMMUNOTHERAPY |
| 7 | TAG 72 | 15 | 47% | 1% | 23 | Search TAG+72 | Search TAG+72 |
| 8 | RADIOIMMUNOTARGETING | 11 | 67% | 0% | 10 | Search RADIOIMMUNOTARGETING | Search RADIOIMMUNOTARGETING |
| 9 | RADIOIMMUNOLOCALIZATION | 11 | 78% | 0% | 7 | Search RADIOIMMUNOLOCALIZATION | Search RADIOIMMUNOLOCALIZATION |
| 10 | RADIOLABELED MONOCLONAL ANTIBODY | 9 | 64% | 0% | 9 | Search RADIOLABELED+MONOCLONAL+ANTIBODY | Search RADIOLABELED+MONOCLONAL+ANTIBODY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RADIOIMMUNODETECTION | 131 | 64% | 4% | 127 |
| 2 | IMMUNOSCINTIGRAPHY | 117 | 50% | 5% | 170 |
| 3 | B723 | 101 | 60% | 3% | 111 |
| 4 | RADIOIMMUNOTHERAPY | 42 | 15% | 8% | 263 |
| 5 | RADIOLABELED ANTIBODIES | 39 | 38% | 3% | 82 |
| 6 | BW 431 26 | 38 | 93% | 0% | 14 |
| 7 | MONOCLONAL ANTIBODY B723 | 37 | 38% | 2% | 76 |
| 8 | FAB2 FRAGMENTS | 35 | 37% | 2% | 76 |
| 9 | ZCE 025 | 33 | 100% | 0% | 13 |
| 10 | RADIOLABELED MONOCLONAL ANTIBODIES | 30 | 39% | 2% | 62 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS | 62 | 52% | 3% | 85 |
| 2 | NUCLEAR MEDICINE-NUKLEARMEDIZIN | 3 | 20% | 0% | 13 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Vehicles, chelators, and radionuclides: Choosing the ''building blocks'' of an effective therapeutic radioimmunoconjugate | 1996 | 136 | 70 | 54% |
| HUMAN IMMUNE-RESPONSE TO MONOCLONAL-ANTIBODIES | 1994 | 208 | 82 | 43% |
| PROBLEMS OF DELIVERY OF MONOCLONAL-ANTIBODIES - PHARMACEUTICAL AND PHARMACOKINETIC SOLUTIONS | 1995 | 109 | 114 | 68% |
| RADIOIMMUNODETECTION IN CANCER IDENTIFICATION | 1992 | 109 | 123 | 81% |
| A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging | 1999 | 21 | 50 | 80% |
| MONOCLONAL-ANTIBODIES IN CANCER-DETECTION AND THERAPY | 1993 | 138 | 123 | 43% |
| Pretargeting strategies for radio-immunoguided tumour localisation and therapy | 1997 | 36 | 34 | 68% |
| Immunoreactivity and prognostic value of tumor-associated glycoprotein 72 in primary gallbladder carcinoma | 2010 | 6 | 15 | 60% |
| Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer | 1998 | 26 | 150 | 63% |
| DIRECT LABELING OF PROTEINS WITH TC-99M | 1991 | 75 | 29 | 72% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PAUL ERRER RADIOPHARMACEUT SCI | 2 | 67% | 0.1% | 2 |
| 2 | RADIOGUIDED SURG UNIT | 2 | 67% | 0.1% | 2 |
| 3 | RADIO NUCLIDE | 2 | 40% | 0.1% | 4 |
| 4 | RADIOIMMUNOTHER Y | 2 | 18% | 0.3% | 9 |
| 5 | CANC CAMPAIGN TARGETING IMAGING GRP | 1 | 50% | 0.1% | 2 |
| 6 | CLIN ONCOLONCOL UNIT | 1 | 100% | 0.1% | 2 |
| 7 | SURG ARADIOGUIDED SURG UNIT | 1 | 100% | 0.1% | 2 |
| 8 | SCI REV | 1 | 40% | 0.1% | 2 |
| 9 | CARDIOL PHC5 | 1 | 50% | 0.0% | 1 |
| 10 | EX U211 | 1 | 50% | 0.0% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000228733 | RADIOIMMUNOTHERAPY//PRETARGETING//Y 90 IBRITUMOMAB TIUXETAN |
| 2 | 0.0000204856 | EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI |
| 3 | 0.0000193498 | UNIT OTOLARYNGOL HEAD NECK SURG//E48//BIOMED RADIAT |
| 4 | 0.0000117984 | GRP PEPTIDE CHEM//BRANCHED POLYPEPTIDES//HUNGARIAN SCI PEPTIDE CHEM GRP |
| 5 | 0.0000106567 | EP CAM//TROP2//EDRECOLOMAB |
| 6 | 0.0000106318 | POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700 |
| 7 | 0.0000101519 | GIRENTUXIMAB//G250//MONOCLONAL ANTIBODY CG250 |
| 8 | 0.0000098122 | AT 211//TARGETED ALPHA THERAPY//BI 213 |
| 9 | 0.0000060080 | HETEROPHILE ANTIBODIES//HUMAN ANTI MOUSE ANTIBODIES HAMA//HETEROPHILIC ANTIBODIES |
| 10 | 0.0000058981 | IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG |